News

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, announced the opening of a new commercial-scale plasmid DNA (pDNA) manufacturing facility at its European center of excellence for cell therapies, in Gosselies, Belgium. The...

Zennova Pharmaceuticals, a Princeton, NJ-based development stage pharmaceutical company focused on complex ophthalmic suspensions and emulsions, hosted a dedication for its manufacturing plant and R&D center on January 11, 2023 in Chengdu, China. The construction of the multi-dosage formulation...

National University of Singapore researchers have gone ahead and revisited a drug which they believe can be a problem solver when it comes to acute leukaemia. The drug, which is referred to as PIK-75, was initially discovered around 15...

2023 can be challenging for the pharmaceutical sector as it will mark the rollout of certain important drug pricing reforms across the US which were put in motion by the last year’s inflation reduction act passage. Not to be...

The FDA has gone on to release the Biosimilar User Fee Amendments III Regulatory Science Pilot Program, called the Research Roadmap, to give out more information on the biosimilar regulatory science research pilot program. The agency has gone on...

Mesothelioma is a rare and aggressive form of cancer that affects the lining of the lungs, abdomen, and heart. Despite being relatively unknown to the general public, it has a significant impact on the medical community. This is due...

One of the latest studies that takes into account the tumour microenvironment of pancreatic cancer puts forth the cause that tumour cells are resistant to immunotherapy, resulting in new strategies for treatment. The study, which is led by Johns Hopkins...